You are here:
- Clinical trials on new oral- and parenteral-active drugs
- New treatment approaches in radioreceptor therapy
- Local sclerotherapy in comparison with alternative treatments
- Treatment of the carcinoid heart disease (Hedinger syndrome) with non-surgical/non-invasive procedures
- Studies to improve the early detection of tumors by molecular imaging using optical and radioactive methods. Eligible candidate ligands for imaging are determined with the aid of a large number of defined fluorescence- or radioactive-labeled receptor ligands.
- Studies to improve the understanding and treatment of carcinoid syndrome, Zollinger-Ellison syndrome and “hypoglycemic” syndrome: By the means of vesicular secretion analyzes and functional analyzes of channel- and receptor-proteins (e.g. GABA receptors, vesicular monoamine transporters, calcium and TRP channels, etc.)
Creation of molecular fingerprints of individual tumors and use of the resulting knowledge of changed molecular parameters for the therapy and clinical practice.